HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hepatitis B Research Network (HBRN) Selected Research

Infections

12/2023Symptoms of Liver Disease During Tenofovir Therapy With or Without Peginterferon: Results from the Hepatitis B Research Network Immune Active Trial.
1/2023Withdrawal of Long-Term Nucleotide Analog Therapy in Chronic Hepatitis B: Outcomes From the Withdrawal Phase of the HBRN Immune Active Treatment Trial.
1/2022Changes in serum hepatitis B surface and e antigen, interferon-inducible protein 10, and aminotransferase levels during combination therapy of immune-tolerant chronic hepatitis B.
1/2021Low Incidence of Adverse Outcomes in Adults With Chronic Hepatitis B Virus Infection in the Era of Antiviral Therapy.
7/2020Maternal knowledge of the risk of vertical transmission and offspring acquisition of hepatitis B.
11/2019Phenotypes of Chronic Hepatitis B in Children From a Large North American Cohort.
1/2019Total Alanine Aminotransferase (ALT) Flares in Pregnant North American Women With Chronic Hepatitis B Infection: Results From a Prospective Observational Study.
1/2019Combination of Entecavir/Peginterferon Alfa-2a in Children With Hepatitis B e Antigen-Positive Immune Tolerant Chronic Hepatitis B Virus Infection.
1/2019Age, race and viral genotype are associated with the prevalence of hepatitis B e antigen in children and adults with chronic hepatitis B.
1/2018Relationship Between Metabolic Syndrome, Alanine Aminotransferase Levels, and Liver Disease Severity in a Multiethnic North American Cohort With Chronic Hepatitis B.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hepatitis B Research Network (HBRN) Research Topics

Disease

14Chronic Hepatitis B
12/2023 - 01/2017
10Infections
12/2023 - 01/2018
9Hepatitis B
12/2023 - 11/2017
4Liver Diseases (Liver Disease)
12/2023 - 01/2017
3Fibrosis (Cirrhosis)
01/2023 - 01/2018
3Virus Diseases (Viral Diseases)
11/2021 - 01/2017
1Fatigue
12/2023
1Pain (Aches)
12/2023
1Coinfection
11/2021
1Hepatocellular Carcinoma (Hepatoma)
01/2019
1Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2018

Drug/Important Bio-Agent (IBA)

10Hepatitis B e AntigensIBA
01/2023 - 01/2017
5DNA (Deoxyribonucleic Acid)IBA
12/2023 - 01/2019
4Alanine Transaminase (SGPT)IBA
12/2023 - 01/2018
4Hepatitis B Surface Antigens (HBsAg)FDA Link
09/2023 - 01/2021
4Antiviral Agents (Antivirals)IBA
01/2021 - 01/2017
2Tenofovir (Viread)FDA Link
12/2023 - 01/2023
1Biomarkers (Surrogate Marker)IBA
12/2023
1NucleotidesIBA
01/2023
1Chemokine CXCL10IBA
01/2022
1Viral AntigensIBA
01/2022
1Transaminases (Aminotransferases)IBA
01/2022
1InterferonsIBA
01/2022
1Viral ProteinsIBA
11/2021
1hepatitis B hyperimmune globulinIBA
07/2020
1VaccinesIBA
07/2020
1entecavirFDA Link
01/2019
1peginterferon alfa-2a (Pegasys)FDA Link
01/2019
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
01/2018

Therapy/Procedure

9Therapeutics
12/2023 - 01/2017
1Liver Transplantation
01/2021